It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2018.
2018 | Bangalore, Karnataka, India | ActiveCurofy Pharmaceuticals Private Limited, a active private limited company, was established on 13 November 2018 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909KA2018PTC118491. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Amandeep Singh (Director), Bikky Kumari Rai (Director), Roshan Kumar (Director). Past directors included Rishi Ranjan, Manish Kumar. It holds ₹3.40 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at #29/2 & 29/3, F Block F No, 301 Bangalore, Karnataka - 560037, Bangalore, Karnataka, 560037.
U51909KA2018PTC118491
118491
13 November 2018
₹1.00 M
₹0.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Curofy Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amandeep Singh | Director | 18 Mar 2020 | Current |
| Bikky Kumari Rai | Director | 13 Nov 2018 | Current |
| Roshan Kumar | Director | 18 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Nov 2020 | Past |
| Pramod Abcsdd | Director | 28 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curofy Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 15.28% decrease. The company also saw a substantial fall in profitability, with a 78.57% decrease in profit. The company's net worth Soared by an impressive increase of 11.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Curofy Pharmaceuticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2025 | Indian Overseas Bank | ₹1.00 M | Open |
| 18 Feb 2022 | Axis Bank Limited | ₹2.40 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Curofy Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curofy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curofy Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Indian Overseas Bank amounted to Rs. 1.00 M with Charge ID 101144578 was registered on 05 Aug 2025. was recorded as a recent event.
The activity Curofy Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Curofy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 2.40 M with Charge ID 100566084 was registered on 18 Feb 2022. was documented.
Progress on Roshan Kumar was appointed as a Director was appointed as a Director on 18 Mar 2021 & has been associated with this company since 4 years 8 months . was documented.
Progress on Amandeep Singh was appointed as a Director was appointed as a Director on 18 Mar 2020 & has been associated with this company since 5 years 8 months . was documented.
The CIN of Curofy Pharmaceuticals Private Limited is U51909KA2018PTC118491.
Curofy Pharmaceuticals Private Limited is headquartered at #29/2 & 29/3, F Block F No, 301 Bangalore, Karnataka - 560037, Bangalore, Karnataka, 560037.
Curofy Pharmaceuticals Private Limited was incorporated on 13 November 2018.
The current directors of Curofy Pharmaceuticals Private Limited are
The primary industry of Curofy Pharmaceuticals Private Limited is Trade.
Curofy Pharmaceuticals Private Limited is unlisted.
The authorized capital of Curofy Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX